Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

NCT00405327

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +25 more
Locations: University of Michigan, Department of Surgery, Pediatric Section Ann Arbor, Michigan, United States

View Trial Details

Completed

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00331409

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer

NCT01938573

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
Locations: VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

NCT02809404

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +19 more
Locations: Radboud university medical center Nijmegen, Netherlands

View Trial Details

Completed

Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

NCT01281488

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

NCT01265901

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Cedars-Siani Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States

Kaiser Permanente Oncology Hematology Clinic Denver, Colorado, United States

Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

View all 105 locations

View Trial Details

Completed

Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development

NCT02106416

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: NYU Langone Medical Center New York, United States

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

NCT00499135

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Carcinoma, +18 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment

NCT01955408

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Meir Medical Center Kfar Saba, Hasharon, Israel

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

NCT01351571

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Aurangabad, India

Delhi, India

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions